Thanks to the Race to Cure Sarcoma events, SFA has invested over $20 million in sarcoma research, funding over 200 grants in 12 countries leading to close to 200 total publications, adding to the sarcoma research discourse. This has led to $26 million+ in additional funding, 10+ clinical trials with 5 additional pending, and 2 patents. Your investment in the RTCS events, is an investment in saving lives.

My wife Michelle courageously fought Hemangioparacytoma (solitary fibrous tumor) for 13 years. Everywhere we turned we were told there was a lack of funding and little in the way of specific treatments or resources. We want to help the cause in developing better, more effective treatment options for those people who have it or will have it, so they can have more options than Michelle did.